<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2021.8235</article-id>
<article-id pub-id-type="publisher-id">OR-0-0-08235</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synergistic effects of co-expression plasmid-based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma <italic>in vitro</italic> and <italic>in vivo</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Songyang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wei</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Kai</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yingchao</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Ji</surname><given-names>Bai</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yahui</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="ppub">
<month>02</month>
<year>2022</year></pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>11</month>
<year>2021</year></pub-date>
<volume>47</volume>
<issue>2</issue>
<elocation-id>24</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Liu et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 32: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="32" page="2501" id="RA1" xlink:href="10.3892/or.2014.3503" ext-link-type="doi">2501-2510</related-article>, 2014; DOI: 10.3892/or.2014.3503</p>
<p>Following the publication of the above paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that various data featured in several of the figures were strikingly similar to data appearing in different form in other articles by different authors. An independent enquiry was launched by the Editorial Office, which revealed that cell migration assay data featured in Fig. 5A and C of the above article had been included in another article written by different authors submitted for publication some 12 months previously.</p>
<p>Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to <italic>Oncology Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
